431 related articles for article (PubMed ID: 9451442)
1. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
Ulrich HD; Schultz PG
J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
[TBL] [Abstract][Full Text] [Related]
2. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for antibody catalysis of a disfavored ring closure reaction.
Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
[TBL] [Abstract][Full Text] [Related]
4. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
5. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
Mouratou B; Stetefeld J
Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of the immunological evolution of antibody 28B4.
Yin J; Mundorff EC; Yang PL; Wendt KU; Hanway D; Stevens RC; Schultz PG
Biochemistry; 2001 Sep; 40(36):10764-73. PubMed ID: 11535051
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
[TBL] [Abstract][Full Text] [Related]
8. Genetic and fluorescence studies of affinity maturation in related antibodies.
Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
[TBL] [Abstract][Full Text] [Related]
10. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
Arkin MR; Wells JA
J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
[TBL] [Abstract][Full Text] [Related]
11. Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
Piatesi A; Hilvert D
Chembiochem; 2004 Apr; 5(4):460-6. PubMed ID: 15185369
[TBL] [Abstract][Full Text] [Related]
12. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
[TBL] [Abstract][Full Text] [Related]
13. Expanding the conformational diversity by random insertions to CDRH2 results in improved anti-estradiol antibodies.
Lamminmäki U; Paupério S; Westerlund-Karlsson A; Karvinen J; Virtanen PL; Lövgren T; Saviranta P
J Mol Biol; 1999 Aug; 291(3):589-602. PubMed ID: 10448039
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of multicatalytic monoclonal antibodies.
Zein HS; da Silva JA; Miyatake K
Mol Immunol; 2010 May; 47(9):1747-56. PubMed ID: 20356628
[TBL] [Abstract][Full Text] [Related]
16. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA
J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784
[TBL] [Abstract][Full Text] [Related]
17. The immunological evolution of catalysis.
Patten PA; Gray NS; Yang PL; Marks CB; Wedemayer GJ; Boniface JJ; Stevens RC; Schultz PG
Science; 1996 Feb; 271(5252):1086-91. PubMed ID: 8599084
[TBL] [Abstract][Full Text] [Related]
18. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
Ohage EC; Wirtz P; Barnikow J; Steipe B
J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
[TBL] [Abstract][Full Text] [Related]
20. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
